Market Overview:
The global pain reliever market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic pain, rising geriatric population, and growing demand for generic drugs. The global pain reliever market is segmented on the basis of type into generic opioids, branded opioids, NSAIDs, and others. Of these segments, the generic opioid segment is expected to grow at the highest CAGR during the forecast period owing to factors such as high affordability and easy availability. On the basis of application, hospitals are expected to account for a major share of this market in 2018 owing to increasing number of surgeries performed across regions.
Product Definition:
A pain reliever is a medication that is used to relieve pain. Pain relievers are often called analgesics or narcotics.
Generic Opioids:
The generic opioids market is expected to grow at a significant rate owing to the increasing demand for pain management therapies. The growing prevalence of chronic diseases such as cancer, arthritis and Alzheimer’s disease has led to an increase in the prescription drug market. According to CDC, around 2 million people die every year due to opioid overdose which leads them into addiction.
Branded Opioids:
Branded Opioids are drugs that are closely related to the natural opioids produced in the body. The major difference between branded and generic opioids is their source of origin. Branded drug products were developed or modified from patented technologies by pharmaceutical companies, whereas generics are available at a much lower cost due to mass production techniques.
Application Insights:
The clinics segment dominated the global pain reliever market in 2017, accounting for a share of over 60%. This is owing to factors such as high usage rates and increasing awareness among patients regarding treatment at pain clinics. For instance, according to the National Pain Foundation, an estimated 1 out of 5 patients visits a primary care doctor for chronic pain every year. Similarly, data published by CDC shows that around 20 million adults aged 18 years or above reported experiencing chronic lower back or neck pain in 2016. Increasing prevalence of these types of disorders coupled with rising awareness about treatment options is expected to drive demand for opioid analgesics at clinics during the forecast period.
Drugstores are projected to be one of the fastest-growing segments due largely to growing penetration and availability of generic opioids sold without a prescription (over-the-counter drugs).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast years due to presence of a large number of key players, availability of advanced treatment options, and high patient awareness levels coupled with relatively higher healthcare expenditure levels as compared to other regions.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising disposable income levels and improving economic conditions in various countries such as China, India, Thailand among others are expected drive regional growth. In addition growing medical tourism industry will also contribute towards increasing demand for pain relief medicines in APAC region over the coming years.
Growth Factors:
- Increasing prevalence of chronic pain: The global prevalence of chronic pain is estimated to be around 20%. This number is expected to grow as the population ages.
- Rising awareness about pain relief options: There has been a growing awareness about various pain relief options in recent years, including both prescription and over-the-counter medications. This has led to an increase in the use of pain relievers.
- Growing demand for combination therapies: Many patients now require multiple types of therapies to manage their chronic pain effectively. This has led to an increase in demand for combination therapies, which include a Pain Reliever as one component thereof.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pain Reliever Market Research Report
By Type
Generic Opioids, Branded Opioids, NSAIDs, Others
By Application
Hospitals, Clinics, Drugstores
By Companies
Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo, Merck, Depomed, Yunnan Baiyao, Teva, J&J, Allergan, Purdue
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
174
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Pain Reliever Market Report Segments:
The global Pain Reliever market is segmented on the basis of:
Types
Generic Opioids, Branded Opioids, NSAIDs, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Drugstores
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- GSK
- Grunenthal
- Bayer
- Sanofi
- Eli Lilly
- AstraZeneca
- Endo
- Merck
- Depomed
- Yunnan Baiyao
- Teva
- J&J
- Allergan
- Purdue
Highlights of The Pain Reliever Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Generic Opioids
- Branded Opioids
- NSAIDs
- Others
- By Application:
- Hospitals
- Clinics
- Drugstores
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pain Reliever Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A pain reliever is a medication that reduces or eliminates pain.
Some of the major companies in the pain reliever market are Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo, Merck, Depomed, Yunnan Baiyao, Teva, J&J, Allergan, Purdue.
The pain reliever market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pain Reliever Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pain Reliever Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pain Reliever Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pain Reliever Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pain Reliever Market Size & Forecast, 2018-2028
4.5.1 Pain Reliever Market Size and Y-o-Y Growth
4.5.2 Pain Reliever Market Absolute $ Opportunity
Chapter 5 Global Pain Reliever Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pain Reliever Market Size Forecast by Type
5.2.1 Generic Opioids
5.2.2 Branded Opioids
5.2.3 NSAIDs
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pain Reliever Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pain Reliever Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Drugstores
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pain Reliever Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pain Reliever Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pain Reliever Analysis and Forecast
9.1 Introduction
9.2 North America Pain Reliever Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pain Reliever Market Size Forecast by Type
9.6.1 Generic Opioids
9.6.2 Branded Opioids
9.6.3 NSAIDs
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pain Reliever Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Drugstores
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pain Reliever Analysis and Forecast
10.1 Introduction
10.2 Europe Pain Reliever Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pain Reliever Market Size Forecast by Type
10.6.1 Generic Opioids
10.6.2 Branded Opioids
10.6.3 NSAIDs
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pain Reliever Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Drugstores
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pain Reliever Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pain Reliever Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pain Reliever Market Size Forecast by Type
11.6.1 Generic Opioids
11.6.2 Branded Opioids
11.6.3 NSAIDs
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pain Reliever Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Drugstores
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pain Reliever Analysis and Forecast
12.1 Introduction
12.2 Latin America Pain Reliever Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pain Reliever Market Size Forecast by Type
12.6.1 Generic Opioids
12.6.2 Branded Opioids
12.6.3 NSAIDs
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pain Reliever Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Drugstores
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pain Reliever Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pain Reliever Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pain Reliever Market Size Forecast by Type
13.6.1 Generic Opioids
13.6.2 Branded Opioids
13.6.3 NSAIDs
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pain Reliever Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Drugstores
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pain Reliever Market: Competitive Dashboard
14.2 Global Pain Reliever Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 GSK
14.3.3 Grunenthal
14.3.4 Bayer
14.3.5 Sanofi
14.3.6 Eli Lilly
14.3.7 AstraZeneca
14.3.8 Endo
14.3.9 Merck
14.3.10 Depomed
14.3.11 Yunnan Baiyao
14.3.12 Teva
14.3.13 J&J
14.3.14 Allergan
14.3.15 Purdue
